Skip to content
PeptideTech
sign in
live116 compounds · 15 vendors listed · 7 graded · audit of 4 Nov 2026 · prices checked 6 Nov 2026independent · grades can’t be bought

Home / Research library / P21

Nootropics

P21: molecular data, studies & sources

P21 is catalogued here as an identity or preparation requiring extra specification. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Source verification is incomplete for this identity. This profile remains available for reference, but is held out of search indexing until supporting molecular or literature records are resolved.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular record not yet resolved

P21 is an ambiguous short name also used for unrelated proteins. No chemistry or papers are assigned by this alias alone.

MF: not assigned · MW: not assigned · Structure: not assigned

Registered clinical trials

Studies registered on ClinicalTrials.gov that list P21 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Human intervention studies

Selected studies in which participants received P21, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

    Preclinical research, reviews & other publications

    Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

    No additional matching publication was retained. The search links below allow further investigation; they are not evidence that a study exists.

      P21 supplier sources

      Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

      P21 for sale: compare prices, sizes and forms from every tracked supplier →

      SupplierRecorded packagesExample source listing
      American PeptidesUSD5mg Vial1 recorded offers5mg Vial · $120.00Checked Nov 6, 2026Supplier listing, P21 5mg Vial, American Peptides, opens in a new tab

      Reference sources & further reading

        The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

        Search for additional research

        These links run searches; their results have not been individually reviewed and can include unrelated compounds.

        Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

        Related research profiles

        Nootropics

        Agomelatine Powder

        C15H17NO2

        243.30 g/mol · PubChem CID 82148

        8 selected publications · 5 human intervention studies · 19 registered trials

        Small molecule · highest stage: Approved in at least one jurisdiction (ChEMBL phase 4)

        Structure, studies & sources →